These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30140989)

  • 1. Serum uric acid and albumin are affected by different variables in Parkinson's disease.
    Hemmati-Dinarvand M; Niknam M; Zununi Vahed S; Samadi N
    Neurol Sci; 2019 Jan; 40(1):187-188. PubMed ID: 30140989
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of serum uric acid, albumin and their interaction on Parkinson's disease.
    Wang L; Hu W; Wang J; Fang F; Cheng G; Jiang Y; Xiao H; Wan Q
    Neurol Sci; 2017 Feb; 38(2):331-336. PubMed ID: 27878402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum uric acid is associated with apathy in early, drug-naïve Parkinson's disease.
    Picillo M; Santangelo G; Moccia M; Erro R; Amboni M; Prestipino E; Longo K; Vitale C; Spina E; Orefice G; Barone P; Pellecchia MT
    J Neural Transm (Vienna); 2016 Apr; 123(4):371-7. PubMed ID: 26739446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urate as a marker of development and progression in Parkinson's disease.
    Constantinescu R; Zetterberg H
    Drugs Today (Barc); 2011 May; 47(5):369-80. PubMed ID: 22013567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of uric acid as a biomarker for Parkinson's disease.
    Huang YX; Luo WF
    Med Hypotheses; 2010 Aug; 75(2):273. PubMed ID: 20409648
    [No Abstract]   [Full Text] [Related]  

  • 6. Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients?
    Moccia M; Picillo M; Erro R; Vitale C; Longo K; Amboni M; Santangelo G; Spina E; De Rosa A; De Michele G; Santoro L; Barone P; Pellecchia MT
    Parkinsonism Relat Disord; 2014 Jul; 20(7):772-5. PubMed ID: 24725754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum uric acid and clinical progression in Parkinson disease: potential biomarker for nigrostriatal failure.
    Schiess M; Oh I
    Arch Neurol; 2008 Jun; 65(6):698-9. PubMed ID: 18541788
    [No Abstract]   [Full Text] [Related]  

  • 8. Uric acid relates to dopamine transporter availability in Parkinson's disease.
    Moccia M; Pappatà S; Erro R; Picillo M; Vitale C; Amboni M; Longo K; Palladino R; Barone P; Pellecchia MT
    Acta Neurol Scand; 2015 Feb; 131(2):127-31. PubMed ID: 25288358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel biosensor may be an important step towards diagnosing early-stage Parkinson's disease.
    Coaker H
    Nanomedicine (Lond); 2014 Mar; 9(3):381-2. PubMed ID: 24746190
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study on uric acid and the related factors associated with cognition in the patients with Parkinson's disease].
    Wang XJ; Luo WF; Wang LJ; Mao CJ; Wang L; Liu CF
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1633-5. PubMed ID: 19957513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: "plasma urate and risk of Parkinson's disease".
    Wise BL; Neogi T; Zhang Y
    Am J Epidemiol; 2008 Mar; 167(6):752-3; author reply 753-4. PubMed ID: 18283033
    [No Abstract]   [Full Text] [Related]  

  • 12. Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey.
    Winquist A; Steenland K; Shankar A
    Mov Disord; 2010 May; 25(7):932-6. PubMed ID: 20310031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agricultural work and reduced circulating uric acid are both associated with initial hospital admission for Parkinson's disease.
    Liu H; Wei X; Yang W; Reynolds GP
    J Neural Transm (Vienna); 2020 May; 127(5):779-783. PubMed ID: 31836905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low plasma uric acid level in Parkinson's disease.
    Annanmaki T; Muuronen A; Murros K
    Mov Disord; 2007 Jun; 22(8):1133-7. PubMed ID: 17443703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease.
    Davis JW; Grandinetti A; Waslien CI; Ross GW; White LR; Morens DM
    Am J Epidemiol; 1996 Sep; 144(5):480-4. PubMed ID: 8781463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum uric acid concentration in Parkinson's disease in southern Spain.
    Jesús S; Pérez I; Cáceres-Redondo MT; Carrillo F; Carballo M; Gómez-Garre P; Mir P
    Eur J Neurol; 2013 Jan; 20(1):208-10. PubMed ID: 22577816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid in Parkinson's disease.
    Schlesinger I; Schlesinger N
    Mov Disord; 2008 Sep; 23(12):1653-7. PubMed ID: 18618666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in Parkinson's disease: a funder's perspective.
    Frasier M; Chowdhury S; Eberling J; Sherer T
    Biomark Med; 2010 Oct; 4(5):723-9. PubMed ID: 20945984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric Acid and Cognitive Function in Older Individuals.
    Tana C; Ticinesi A; Prati B; Nouvenne A; Meschi T
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30060474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Problems associated with fluid biomarkers for Parkinson's disease.
    Nyhlén J; Constantinescu R; Zetterberg H
    Biomark Med; 2010 Oct; 4(5):671-81. PubMed ID: 20945980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.